Mostrar el registro sencillo del ítem

CoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections.

dc.rights.licenseopenen_US
dc.contributor.authorCOUVÉ, Eloïse
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorLAHOUATI, Marin
dc.contributor.authorLEITAO, Julie
dc.contributor.authorMEIRELES, Vasco Dias
dc.contributor.authorDAUCHY, Frederic
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorXUEREB, Fabien
dc.date.accessioned2025-06-02T07:54:03Z
dc.date.available2025-06-02T07:54:03Z
dc.date.issued2025-05-28
dc.identifier.issn2666-9919en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206805
dc.description.abstractEnPatients with bone and joint infections (BJI) are part of a complex care pathway. This study aimed to evaluate the economic impact of clinical pharmacist-led interventions in the management of BJI patients. We performed a retrospective study documenting all pharmacist-led interventions (PI). Their impact was assessed using the clinical economic and organizational scale (CLEO SFPC). The probability of adverse drug events (ADE) in the absence of PI was assessed by a panel of three experts. Cost avoidance was calculated for PIs with major clinical impact using a cost of €5,331 per event, multiplied by the probability of ADE occurrence. A total of 41 PIs had a major clinical impact. Cost avoidance associated with the intervention of a pharmacist was estimated at €83,750.01 during the study. The implementation of pharmacist-led interventions in the management of patients with BJI helps avoid preventable healthcare costs.
dc.language.isoENen_US
dc.subject.enAdverse events; Antibiotics; Bone and joint infection; Clinical pharmacy; Medication safety.
dc.title.enCoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections.
dc.title.alternativeInfect Dis Nowen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.idnow.2025.105104en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed40447052en_US
bordeaux.journalInfectious Diseases Nowen_US
bordeaux.page105104en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires (BMC) - UMR 1034en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-05092497
hal.version1
hal.date.transferred2025-06-02T07:54:07Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Infectious%20Diseases%20Now&rft.date=2025-05-28&rft.spage=105104&rft.epage=105104&rft.eissn=2666-9919&rft.issn=2666-9919&rft.au=COUV%C3%89,%20Elo%C3%AFse&LAHOUATI,%20Marin&LEITAO,%20Julie&MEIRELES,%20Vasco%20Dias&DAUCHY,%20Frederic&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem